![Virginia Hallner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Virginia Hallner
Plus aucun poste en cours
Profil
Ms. Hallner joined POSCO in 2002.
She began her career in 1981 as an auditor with the international accounting firm of PricewaterhouseCoopers.
Ms. Hallner received her BS degree in Business Administration from San Diego State University and is a recent graduate of the Venture Capital Institute.
Anciens postes connus de Virginia Hallner
| Sociétés | Poste | Fin |
|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 31/12/2001 |
POSCO BioVentures, Inc.
 POSCO BioVentures, Inc. Investment ManagersFinance POSCO BioVentures invests in companies located in the United States. The firm focuses on therapeutics, diagnostics, platform technologies and non-life sciences companies. It provides financing for seed, early and later stage capital requirements. | Directeur Financier/CFO | 01/10/2009 |
Formation de Virginia Hallner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
POSCO BioVentures, Inc.
POSCO BioVentures, Inc. Investment ManagersFinance POSCO BioVentures invests in companies located in the United States. The firm focuses on therapeutics, diagnostics, platform technologies and non-life sciences companies. It provides financing for seed, early and later stage capital requirements. | Finance |
